Medical Care
Global Intravenous(IV) Therapy and Vein Access Market Research Report 2024
- Jan 20, 24
- ID: 19742
- Pages: 74
- Figures: 143
- Views: 31
IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.
The global Intravenous(IV) Therapy and Vein Access market was valued at US$ 35670 million in 2023 and is anticipated to reach US$ 46480 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intravenous(IV) Therapy and Vein Access, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous(IV) Therapy and Vein Access.
Report Scope
The Intravenous(IV) Therapy and Vein Access market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous(IV) Therapy and Vein Access market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous(IV) Therapy and Vein Access companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex
Segment by Type
Infusion Pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other
Segment by Application
Hospital
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous(IV) Therapy and Vein Access companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Intravenous(IV) Therapy and Vein Access market was valued at US$ 35670 million in 2023 and is anticipated to reach US$ 46480 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intravenous(IV) Therapy and Vein Access, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous(IV) Therapy and Vein Access.
Report Scope
The Intravenous(IV) Therapy and Vein Access market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous(IV) Therapy and Vein Access market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous(IV) Therapy and Vein Access companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex
Segment by Type
Infusion Pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other
Segment by Application
Hospital
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous(IV) Therapy and Vein Access companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infusion Pumps
1.2.3 Implantable Ports
1.2.4 Intravenous Catheters
1.2.5 Hypodermic Needles
1.2.6 Other
1.3 Market by Application
1.3.1 Global Intravenous(IV) Therapy and Vein Access Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intravenous(IV) Therapy and Vein Access Market Perspective (2019-2030)
2.2 Intravenous(IV) Therapy and Vein Access Growth Trends by Region
2.2.1 Global Intravenous(IV) Therapy and Vein Access Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Intravenous(IV) Therapy and Vein Access Historic Market Size by Region (2019-2024)
2.2.3 Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Region (2025-2030)
2.3 Intravenous(IV) Therapy and Vein Access Market Dynamics
2.3.1 Intravenous(IV) Therapy and Vein Access Industry Trends
2.3.2 Intravenous(IV) Therapy and Vein Access Market Drivers
2.3.3 Intravenous(IV) Therapy and Vein Access Market Challenges
2.3.4 Intravenous(IV) Therapy and Vein Access Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intravenous(IV) Therapy and Vein Access Players by Revenue
3.1.1 Global Top Intravenous(IV) Therapy and Vein Access Players by Revenue (2019-2024)
3.1.2 Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Players (2019-2024)
3.2 Global Intravenous(IV) Therapy and Vein Access Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intravenous(IV) Therapy and Vein Access Revenue
3.4 Global Intravenous(IV) Therapy and Vein Access Market Concentration Ratio
3.4.1 Global Intravenous(IV) Therapy and Vein Access Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intravenous(IV) Therapy and Vein Access Revenue in 2023
3.5 Intravenous(IV) Therapy and Vein Access Key Players Head office and Area Served
3.6 Key Players Intravenous(IV) Therapy and Vein Access Product Solution and Service
3.7 Date of Enter into Intravenous(IV) Therapy and Vein Access Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intravenous(IV) Therapy and Vein Access Breakdown Data by Type
4.1 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Type (2019-2024)
4.2 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Type (2025-2030)
5 Intravenous(IV) Therapy and Vein Access Breakdown Data by Application
5.1 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Application (2019-2024)
5.2 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
6.2 North America Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
6.4 North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
7.2 Europe Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
7.4 Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
8.2 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2019-2024)
8.4 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
9.2 Latin America Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
9.4 Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
10.2 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
10.4 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 B. Braun
11.1.1 B. Braun Company Detail
11.1.2 B. Braun Business Overview
11.1.3 B. Braun Intravenous(IV) Therapy and Vein Access Introduction
11.1.4 B. Braun Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.1.5 B. Braun Recent Development
11.2 Baxter International
11.2.1 Baxter International Company Detail
11.2.2 Baxter International Business Overview
11.2.3 Baxter International Intravenous(IV) Therapy and Vein Access Introduction
11.2.4 Baxter International Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.2.5 Baxter International Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Introduction
11.3.4 Becton Dickinson Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 C. R. Bard
11.4.1 C. R. Bard Company Detail
11.4.2 C. R. Bard Business Overview
11.4.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Introduction
11.4.4 C. R. Bard Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.4.5 C. R. Bard Recent Development
11.5 Fresenius Kabi
11.5.1 Fresenius Kabi Company Detail
11.5.2 Fresenius Kabi Business Overview
11.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Introduction
11.5.4 Fresenius Kabi Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.5.5 Fresenius Kabi Recent Development
11.6 Hospira(ICU Medical)
11.6.1 Hospira(ICU Medical) Company Detail
11.6.2 Hospira(ICU Medical) Business Overview
11.6.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Introduction
11.6.4 Hospira(ICU Medical) Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.6.5 Hospira(ICU Medical) Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Detail
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Intravenous(IV) Therapy and Vein Access Introduction
11.7.4 Medtronic Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.7.5 Medtronic Recent Development
11.8 Smiths Group
11.8.1 Smiths Group Company Detail
11.8.2 Smiths Group Business Overview
11.8.3 Smiths Group Intravenous(IV) Therapy and Vein Access Introduction
11.8.4 Smiths Group Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.8.5 Smiths Group Recent Development
11.9 Teleflex
11.9.1 Teleflex Company Detail
11.9.2 Teleflex Business Overview
11.9.3 Teleflex Intravenous(IV) Therapy and Vein Access Introduction
11.9.4 Teleflex Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.9.5 Teleflex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infusion Pumps
1.2.3 Implantable Ports
1.2.4 Intravenous Catheters
1.2.5 Hypodermic Needles
1.2.6 Other
1.3 Market by Application
1.3.1 Global Intravenous(IV) Therapy and Vein Access Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intravenous(IV) Therapy and Vein Access Market Perspective (2019-2030)
2.2 Intravenous(IV) Therapy and Vein Access Growth Trends by Region
2.2.1 Global Intravenous(IV) Therapy and Vein Access Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Intravenous(IV) Therapy and Vein Access Historic Market Size by Region (2019-2024)
2.2.3 Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Region (2025-2030)
2.3 Intravenous(IV) Therapy and Vein Access Market Dynamics
2.3.1 Intravenous(IV) Therapy and Vein Access Industry Trends
2.3.2 Intravenous(IV) Therapy and Vein Access Market Drivers
2.3.3 Intravenous(IV) Therapy and Vein Access Market Challenges
2.3.4 Intravenous(IV) Therapy and Vein Access Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intravenous(IV) Therapy and Vein Access Players by Revenue
3.1.1 Global Top Intravenous(IV) Therapy and Vein Access Players by Revenue (2019-2024)
3.1.2 Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Players (2019-2024)
3.2 Global Intravenous(IV) Therapy and Vein Access Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intravenous(IV) Therapy and Vein Access Revenue
3.4 Global Intravenous(IV) Therapy and Vein Access Market Concentration Ratio
3.4.1 Global Intravenous(IV) Therapy and Vein Access Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intravenous(IV) Therapy and Vein Access Revenue in 2023
3.5 Intravenous(IV) Therapy and Vein Access Key Players Head office and Area Served
3.6 Key Players Intravenous(IV) Therapy and Vein Access Product Solution and Service
3.7 Date of Enter into Intravenous(IV) Therapy and Vein Access Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intravenous(IV) Therapy and Vein Access Breakdown Data by Type
4.1 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Type (2019-2024)
4.2 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Type (2025-2030)
5 Intravenous(IV) Therapy and Vein Access Breakdown Data by Application
5.1 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Application (2019-2024)
5.2 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
6.2 North America Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
6.4 North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
7.2 Europe Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
7.4 Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
8.2 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2019-2024)
8.4 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
9.2 Latin America Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
9.4 Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size (2019-2030)
10.2 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024)
10.4 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 B. Braun
11.1.1 B. Braun Company Detail
11.1.2 B. Braun Business Overview
11.1.3 B. Braun Intravenous(IV) Therapy and Vein Access Introduction
11.1.4 B. Braun Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.1.5 B. Braun Recent Development
11.2 Baxter International
11.2.1 Baxter International Company Detail
11.2.2 Baxter International Business Overview
11.2.3 Baxter International Intravenous(IV) Therapy and Vein Access Introduction
11.2.4 Baxter International Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.2.5 Baxter International Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Introduction
11.3.4 Becton Dickinson Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 C. R. Bard
11.4.1 C. R. Bard Company Detail
11.4.2 C. R. Bard Business Overview
11.4.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Introduction
11.4.4 C. R. Bard Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.4.5 C. R. Bard Recent Development
11.5 Fresenius Kabi
11.5.1 Fresenius Kabi Company Detail
11.5.2 Fresenius Kabi Business Overview
11.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Introduction
11.5.4 Fresenius Kabi Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.5.5 Fresenius Kabi Recent Development
11.6 Hospira(ICU Medical)
11.6.1 Hospira(ICU Medical) Company Detail
11.6.2 Hospira(ICU Medical) Business Overview
11.6.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Introduction
11.6.4 Hospira(ICU Medical) Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.6.5 Hospira(ICU Medical) Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Detail
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Intravenous(IV) Therapy and Vein Access Introduction
11.7.4 Medtronic Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.7.5 Medtronic Recent Development
11.8 Smiths Group
11.8.1 Smiths Group Company Detail
11.8.2 Smiths Group Business Overview
11.8.3 Smiths Group Intravenous(IV) Therapy and Vein Access Introduction
11.8.4 Smiths Group Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.8.5 Smiths Group Recent Development
11.9 Teleflex
11.9.1 Teleflex Company Detail
11.9.2 Teleflex Business Overview
11.9.3 Teleflex Intravenous(IV) Therapy and Vein Access Introduction
11.9.4 Teleflex Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
11.9.5 Teleflex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Infusion Pumps
Table 3. Key Players of Implantable Ports
Table 4. Key Players of Intravenous Catheters
Table 5. Key Players of Hypodermic Needles
Table 6. Key Players of Other
Table 7. Global Intravenous(IV) Therapy and Vein Access Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Intravenous(IV) Therapy and Vein Access Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Intravenous(IV) Therapy and Vein Access Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Intravenous(IV) Therapy and Vein Access Market Share by Region (2019-2024)
Table 11. Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Intravenous(IV) Therapy and Vein Access Market Share by Region (2025-2030)
Table 13. Intravenous(IV) Therapy and Vein Access Market Trends
Table 14. Intravenous(IV) Therapy and Vein Access Market Drivers
Table 15. Intravenous(IV) Therapy and Vein Access Market Challenges
Table 16. Intravenous(IV) Therapy and Vein Access Market Restraints
Table 17. Global Intravenous(IV) Therapy and Vein Access Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Intravenous(IV) Therapy and Vein Access Market Share by Players (2019-2024)
Table 19. Global Top Intravenous(IV) Therapy and Vein Access Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous(IV) Therapy and Vein Access as of 2023)
Table 20. Ranking of Global Top Intravenous(IV) Therapy and Vein Access Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Intravenous(IV) Therapy and Vein Access Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Intravenous(IV) Therapy and Vein Access Product Solution and Service
Table 24. Date of Enter into Intravenous(IV) Therapy and Vein Access Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Intravenous(IV) Therapy and Vein Access Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Type (2019-2024)
Table 28. Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Type (2025-2030)
Table 30. Global Intravenous(IV) Therapy and Vein Access Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Application (2019-2024)
Table 32. Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Application (2025-2030)
Table 34. North America Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030) & (US$ Million)
Table 49. B. Braun Company Detail
Table 50. B. Braun Business Overview
Table 51. B. Braun Intravenous(IV) Therapy and Vein Access Product
Table 52. B. Braun Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 53. B. Braun Recent Development
Table 54. Baxter International Company Detail
Table 55. Baxter International Business Overview
Table 56. Baxter International Intravenous(IV) Therapy and Vein Access Product
Table 57. Baxter International Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 58. Baxter International Recent Development
Table 59. Becton Dickinson Company Detail
Table 60. Becton Dickinson Business Overview
Table 61. Becton Dickinson Intravenous(IV) Therapy and Vein Access Product
Table 62. Becton Dickinson Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 63. Becton Dickinson Recent Development
Table 64. C. R. Bard Company Detail
Table 65. C. R. Bard Business Overview
Table 66. C. R. Bard Intravenous(IV) Therapy and Vein Access Product
Table 67. C. R. Bard Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 68. C. R. Bard Recent Development
Table 69. Fresenius Kabi Company Detail
Table 70. Fresenius Kabi Business Overview
Table 71. Fresenius Kabi Intravenous(IV) Therapy and Vein Access Product
Table 72. Fresenius Kabi Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 73. Fresenius Kabi Recent Development
Table 74. Hospira(ICU Medical) Company Detail
Table 75. Hospira(ICU Medical) Business Overview
Table 76. Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Product
Table 77. Hospira(ICU Medical) Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 78. Hospira(ICU Medical) Recent Development
Table 79. Medtronic Company Detail
Table 80. Medtronic Business Overview
Table 81. Medtronic Intravenous(IV) Therapy and Vein Access Product
Table 82. Medtronic Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 83. Medtronic Recent Development
Table 84. Smiths Group Company Detail
Table 85. Smiths Group Business Overview
Table 86. Smiths Group Intravenous(IV) Therapy and Vein Access Product
Table 87. Smiths Group Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 88. Smiths Group Recent Development
Table 89. Teleflex Company Detail
Table 90. Teleflex Business Overview
Table 91. Teleflex Intravenous(IV) Therapy and Vein Access Product
Table 92. Teleflex Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 93. Teleflex Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intravenous(IV) Therapy and Vein Access Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Intravenous(IV) Therapy and Vein Access Market Share by Type: 2023 VS 2030
Figure 3. Infusion Pumps Features
Figure 4. Implantable Ports Features
Figure 5. Intravenous Catheters Features
Figure 6. Hypodermic Needles Features
Figure 7. Other Features
Figure 8. Global Intravenous(IV) Therapy and Vein Access Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Intravenous(IV) Therapy and Vein Access Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Clinics Case Studies
Figure 12. Other Case Studies
Figure 13. Intravenous(IV) Therapy and Vein Access Report Years Considered
Figure 14. Global Intravenous(IV) Therapy and Vein Access Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Intravenous(IV) Therapy and Vein Access Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Intravenous(IV) Therapy and Vein Access Market Share by Region: 2023 VS 2030
Figure 17. Global Intravenous(IV) Therapy and Vein Access Market Share by Players in 2023
Figure 18. Global Top Intravenous(IV) Therapy and Vein Access Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous(IV) Therapy and Vein Access as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Intravenous(IV) Therapy and Vein Access Revenue in 2023
Figure 20. North America Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Intravenous(IV) Therapy and Vein Access Market Share by Country (2019-2030)
Figure 22. United States Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Intravenous(IV) Therapy and Vein Access Market Share by Country (2019-2030)
Figure 26. Germany Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Share by Region (2019-2030)
Figure 34. China Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Intravenous(IV) Therapy and Vein Access Market Share by Country (2019-2030)
Figure 42. Mexico Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Share by Country (2019-2030)
Figure 46. Turkey Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. B. Braun Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 49. Baxter International Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 50. Becton Dickinson Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 51. C. R. Bard Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 52. Fresenius Kabi Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 53. Hospira(ICU Medical) Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 54. Medtronic Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 55. Smiths Group Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 56. Teleflex Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Infusion Pumps
Table 3. Key Players of Implantable Ports
Table 4. Key Players of Intravenous Catheters
Table 5. Key Players of Hypodermic Needles
Table 6. Key Players of Other
Table 7. Global Intravenous(IV) Therapy and Vein Access Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Intravenous(IV) Therapy and Vein Access Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Intravenous(IV) Therapy and Vein Access Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Intravenous(IV) Therapy and Vein Access Market Share by Region (2019-2024)
Table 11. Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Intravenous(IV) Therapy and Vein Access Market Share by Region (2025-2030)
Table 13. Intravenous(IV) Therapy and Vein Access Market Trends
Table 14. Intravenous(IV) Therapy and Vein Access Market Drivers
Table 15. Intravenous(IV) Therapy and Vein Access Market Challenges
Table 16. Intravenous(IV) Therapy and Vein Access Market Restraints
Table 17. Global Intravenous(IV) Therapy and Vein Access Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Intravenous(IV) Therapy and Vein Access Market Share by Players (2019-2024)
Table 19. Global Top Intravenous(IV) Therapy and Vein Access Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous(IV) Therapy and Vein Access as of 2023)
Table 20. Ranking of Global Top Intravenous(IV) Therapy and Vein Access Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Intravenous(IV) Therapy and Vein Access Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Intravenous(IV) Therapy and Vein Access Product Solution and Service
Table 24. Date of Enter into Intravenous(IV) Therapy and Vein Access Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Intravenous(IV) Therapy and Vein Access Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Type (2019-2024)
Table 28. Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Type (2025-2030)
Table 30. Global Intravenous(IV) Therapy and Vein Access Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Application (2019-2024)
Table 32. Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Application (2025-2030)
Table 34. North America Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2025-2030) & (US$ Million)
Table 49. B. Braun Company Detail
Table 50. B. Braun Business Overview
Table 51. B. Braun Intravenous(IV) Therapy and Vein Access Product
Table 52. B. Braun Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 53. B. Braun Recent Development
Table 54. Baxter International Company Detail
Table 55. Baxter International Business Overview
Table 56. Baxter International Intravenous(IV) Therapy and Vein Access Product
Table 57. Baxter International Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 58. Baxter International Recent Development
Table 59. Becton Dickinson Company Detail
Table 60. Becton Dickinson Business Overview
Table 61. Becton Dickinson Intravenous(IV) Therapy and Vein Access Product
Table 62. Becton Dickinson Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 63. Becton Dickinson Recent Development
Table 64. C. R. Bard Company Detail
Table 65. C. R. Bard Business Overview
Table 66. C. R. Bard Intravenous(IV) Therapy and Vein Access Product
Table 67. C. R. Bard Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 68. C. R. Bard Recent Development
Table 69. Fresenius Kabi Company Detail
Table 70. Fresenius Kabi Business Overview
Table 71. Fresenius Kabi Intravenous(IV) Therapy and Vein Access Product
Table 72. Fresenius Kabi Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 73. Fresenius Kabi Recent Development
Table 74. Hospira(ICU Medical) Company Detail
Table 75. Hospira(ICU Medical) Business Overview
Table 76. Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Product
Table 77. Hospira(ICU Medical) Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 78. Hospira(ICU Medical) Recent Development
Table 79. Medtronic Company Detail
Table 80. Medtronic Business Overview
Table 81. Medtronic Intravenous(IV) Therapy and Vein Access Product
Table 82. Medtronic Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 83. Medtronic Recent Development
Table 84. Smiths Group Company Detail
Table 85. Smiths Group Business Overview
Table 86. Smiths Group Intravenous(IV) Therapy and Vein Access Product
Table 87. Smiths Group Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 88. Smiths Group Recent Development
Table 89. Teleflex Company Detail
Table 90. Teleflex Business Overview
Table 91. Teleflex Intravenous(IV) Therapy and Vein Access Product
Table 92. Teleflex Revenue in Intravenous(IV) Therapy and Vein Access Business (2019-2024) & (US$ Million)
Table 93. Teleflex Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intravenous(IV) Therapy and Vein Access Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Intravenous(IV) Therapy and Vein Access Market Share by Type: 2023 VS 2030
Figure 3. Infusion Pumps Features
Figure 4. Implantable Ports Features
Figure 5. Intravenous Catheters Features
Figure 6. Hypodermic Needles Features
Figure 7. Other Features
Figure 8. Global Intravenous(IV) Therapy and Vein Access Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Intravenous(IV) Therapy and Vein Access Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Clinics Case Studies
Figure 12. Other Case Studies
Figure 13. Intravenous(IV) Therapy and Vein Access Report Years Considered
Figure 14. Global Intravenous(IV) Therapy and Vein Access Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Intravenous(IV) Therapy and Vein Access Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Intravenous(IV) Therapy and Vein Access Market Share by Region: 2023 VS 2030
Figure 17. Global Intravenous(IV) Therapy and Vein Access Market Share by Players in 2023
Figure 18. Global Top Intravenous(IV) Therapy and Vein Access Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous(IV) Therapy and Vein Access as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Intravenous(IV) Therapy and Vein Access Revenue in 2023
Figure 20. North America Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Intravenous(IV) Therapy and Vein Access Market Share by Country (2019-2030)
Figure 22. United States Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Intravenous(IV) Therapy and Vein Access Market Share by Country (2019-2030)
Figure 26. Germany Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Share by Region (2019-2030)
Figure 34. China Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Intravenous(IV) Therapy and Vein Access Market Share by Country (2019-2030)
Figure 42. Mexico Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Share by Country (2019-2030)
Figure 46. Turkey Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Intravenous(IV) Therapy and Vein Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. B. Braun Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 49. Baxter International Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 50. Becton Dickinson Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 51. C. R. Bard Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 52. Fresenius Kabi Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 53. Hospira(ICU Medical) Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 54. Medtronic Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 55. Smiths Group Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 56. Teleflex Revenue Growth Rate in Intravenous(IV) Therapy and Vein Access Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Paint Leveling Agent Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Adhesion Promoters Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Rheological Additives Market Insights, Forecast to 2030
Dec 22, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232